However, our findings of changes in serum levels of BAFF over time in association with changes in disease activity was similar to a longitudinal follow-up in systemic sclerosis (SSc), early RA, and SLE [8, 41, 42], indicating that BAFF may have a higher impact in early disease. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.